Login

Healthcare

00:00:00
SkinBioTherapeutics will "continue to be flexible enough to adapt to opportunities" - Stuart Ashman Chief Executive, Skinbiotherapeutics
00:00:00
SkinBioTherapeutics (SBTX) - Stuart Ashman, CEO
00:00:00
SkinBio Therapeutics (SBTX) is a life science company - Stuart Ashman Chief Executive, Skinbiotherapeutics
00:00:00
Introducing Silence Therapeutics - Mark Rothera, President and CEO of Silence Therapeutics
00:00:00
Silence Therapeutics - The GOLDen future of RNAi Research - Mark Rothera, President and CEO of Silence Therapeutics
00:00:00
CEO Andrew Morris talks about the big steps SQI has taken in its corporate development - Andrew Morris DIRECTOR AND CHIEF EXECUTIVE OFFICER, SQI Diagnostics Inc
00:00:00
SQI Diagnostics (TSXV:SQD) Can Multiplex a Blood Test: CEO - Andrew Morris DIRECTOR AND CHIEF EXECUTIVE OFFICER, SQI Diagnostics Inc
00:00:00
Sienna Cancer Diagnostics (ASX:SDX) update - Matthew Hoskin, CEO, Sienna Cancer Diagnostics Ltd
00:00:00
Sienna Cancer Diagnostics (ASX:SDX) talks IVD test sales - Matthew Hoskin, CEO, Sienna Cancer Diagnostics Ltd
00:00:00
Shield Therapeutics' present drive for US launch success of iron deficiency product Accrufer - Greg Madison Chief Executive Officer, Shield Therapeutics P
00:00:00
Shield Therapeutics "couldn't be more pleased" with Viatris collaboration - Greg Madison Chief Executive Officer, Shield Therapeutics P
00:00:00
Shield Therapeutics talks extension of cash runway following US$10 million financing - Greg Madison Chief Executive Officer, Shield Therapeutics P
00:00:00
Shield Therapeutics 'delivered an excellent first half' with Accrufer powering ahead in the US - Greg Madison Chief Executive Officer, Shield Therapeutics P
00:00:00
Shield Therapeutics "ended 2022 in a very very productive state" - Greg Madison Chief Executive Officer, Shield Therapeutics P
00:00:00
Interview with Dr. Philip Toleikis, President & CEO of Sernova Corp. - Dr. Philip Toleikis, President & CEO of Sernova Corp.
00:00:00
CEO Pia Renaudin presents Senzime - Pia Renaudin, CEO, Senzime AB (publ)

© 2026 Nehu